dr. wang-gillam on results of a phase 1 study with defactinib in pancreatic ductal adenocarcinoma
Published 4 years ago • 149 plays • Length 0:58Download video MP4
Download video MP3
Similar videos
-
0:51
dr. wang-gillam on next steps with defactinib combo in pancreatic ductal adenocarcinoma
-
0:43
dr. wang-gillam on folfirinox combo for pancreatic adenocarcinoma
-
1:12:13
approach to neoadjuvant treated pancreatic ductal adenocarcinoma - dr. wang
-
4:36
phase i/ii results: first-line nalirifox in patients with pancreatic ductal adenocarcinoma
-
23:26
pancreatic cancer vaccines with amazing results in phase i
-
1:38
dr. wang-gillam discusses a monocyte-targeting agent for pancreatic cancer
-
1:10
dr. andrea wang-gillam- pedal the cause
-
1:17
dr. kundranda on the need for novel treatments in pancreatic ductal adenocarcinoma
-
46:32
pancreatic ductal adenocarcinoma and variants - dr. wood
-
1:02
dr. hendifar on the halo-202 study in metastatic pancreatic ductal adenocarcinoma
-
2:00
andrea wang-gillam, md, phd
-
0:34
targeted therapy for pancreatic ductal adenocarcinoma: mechanisms and clinical study | rtcl.tv
-
1:13
new pancreatic ductal adenocarcinoma clinical trial: rmc 6236 for pancreatic ductal adenocarcinoma
-
17:32
pancreatic ductal adenocarcinoma versus mass forming pancreatitis delivered by prof. wolfgang schima
-
19:44
targeted therapy for pancreatic ductal adenocarcinoma
-
0:40
1l nalirifox in advanced or metastatic pdac
-
1:12
supporting ngs for pancreatic ductal adenocarcinoma
-
9:42
jae young lee: folfirinox plus high intensity fus for pancreatic ductal adenocarcinoma
-
3:16
a novel combination therapy for pancreatic ductal adenocarcinoma - dr scott gerber